These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 14734855)
21. Cross reactivity of enterohemorrhagic Escherichia coli O157:H7-specific sera with non-O157 serotypes. Asper DJ; Sekirov I; Finlay BB; Rogan D; Potter AA Vaccine; 2007 Nov; 25(49):8262-9. PubMed ID: 17980466 [TBL] [Abstract][Full Text] [Related]
22. The use of serodiagnosis in the retrospective investigation of a nursery outbreak associated with Escherichia coli O157:H7. Cheasty T; Robertson R; Chart H; Mannion P; Syed Q; Garvey R; Rowe B J Clin Pathol; 1998 Jul; 51(7):498-501. PubMed ID: 9797724 [TBL] [Abstract][Full Text] [Related]
23. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome. Chart H; Perry NT Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202 [TBL] [Abstract][Full Text] [Related]
24. Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus. Jenkins C; Chart H; Smith HR; Hartland EL; Batchelor M; Delahay RM; Dougan G; Frankel G J Med Microbiol; 2000 Jan; 49(1):97-101. PubMed ID: 10628831 [TBL] [Abstract][Full Text] [Related]
25. Vaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coli (EHEC) Factor for Adherence-1 Gene (efa-1') Confers Protective Immunity to Mice Infected with E. coli O157:H7. Riquelme-Neira R; Rivera A; Sáez D; Fernández P; Osorio G; del Canto F; Salazar JC; Vidal RM; Oñate A Front Cell Infect Microbiol; 2015; 5():104. PubMed ID: 26835434 [TBL] [Abstract][Full Text] [Related]
26. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome. Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387 [TBL] [Abstract][Full Text] [Related]
27. Analysis of saliva for antibodies to the LPS of Escherichia coli O157 in patients with serum antibodies to E. coli O157 LPS. Chart H; Perry NT; Willshaw GA; Cheasty T J Med Microbiol; 2003 Jul; 52(Pt 7):569-572. PubMed ID: 12808078 [TBL] [Abstract][Full Text] [Related]
28. [Sporadic cases of hemolytic uremic syndrome and hemorrhagic colitis with serum IgM antibodies to lipopolysaccharides of enterohemorrhagic Escherichia coli O157]. Shiomi M; Togawa M Nihon Rinsho; 1997 Mar; 55(3):686-92. PubMed ID: 9086782 [TBL] [Abstract][Full Text] [Related]
29. Structure and serologic properties of O-specific polysaccharide from Citrobacter freundii possessing cross-reactivity with Escherichia coli O157:H7. Nishiuchi Y; Doe M; Hotta H; Kobayashi K FEMS Immunol Med Microbiol; 2000 Jun; 28(2):163-71. PubMed ID: 10799808 [TBL] [Abstract][Full Text] [Related]
30. Isotype-specific antibody responses against Escherichia coli O157:H7 locus of enterocyte effacement proteins in adult beef cattle following experimental infection. Bretschneider G; Berberov EM; Moxley RA Vet Immunol Immunopathol; 2007 Aug; 118(3-4):229-38. PubMed ID: 17617472 [TBL] [Abstract][Full Text] [Related]
31. Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157. Westerman RB; He Y; Keen JE; Littledike ET; Kwang J J Clin Microbiol; 1997 Mar; 35(3):679-84. PubMed ID: 9041412 [TBL] [Abstract][Full Text] [Related]
32. Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome. Ludwig K; Bitzan M; Zimmermann S; Kloth M; Ruder H; Müller-Wiefel DE J Infect Dis; 1996 Nov; 174(5):1028-39. PubMed ID: 8896505 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of a latex agglutination kit for the detection of human antibodies to the lipopolysaccharide of Escherichia coli O157, following infection with verocytotoxin-producing E. coli O157. Chart H Lett Appl Microbiol; 1999 Dec; 29(6):434-6. PubMed ID: 10664989 [TBL] [Abstract][Full Text] [Related]
34. [Bacterial agglutination test for diagnosis of enterohemorrhagic Escherichia coli(EHEC) infection]. Kobayashi K Nihon Rinsho; 1997 Mar; 55(3):675-9. PubMed ID: 9086780 [TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of latex agglutination tests for the detection of human antibodies to the lipopolysaccharides of verocytotoxin-producing Escherichia coli (VTEC) serogroups O157 and non-O157. Rastawicki W; Chróst A; Gielarowiec K J Microbiol Methods; 2017 Sep; 140():74-76. PubMed ID: 28732694 [TBL] [Abstract][Full Text] [Related]
36. Antibodies among healthy population of developing countries against enterohaemorrhagic Escherichia coli O157:H7. Voravuthikunchai SP; Chaowana C; Perepat P; Iida T; Honda T J Health Popul Nutr; 2005 Dec; 23(4):305-10. PubMed ID: 16599100 [TBL] [Abstract][Full Text] [Related]
37. [Development of O-serogroup serodiagnosis for patients with hemolytic uremic syndrome by Ec-LPS array]. Amano K; Yatsuyanagi J; Saito S Kansenshogaku Zasshi; 2007 Jan; 81(1):26-32. PubMed ID: 17338313 [TBL] [Abstract][Full Text] [Related]
38. A murine model of enterohemorrhagic Escherichia coli O157:H7 infection to assess immunopotentiating activity of drugs on mucosal immunity: effect of drugs. Nagano K; Sugisaki T; Taguchi K; Hara T; Naiki M; Mori H J Pharmacol Sci; 2003 Mar; 91(3):219-28. PubMed ID: 12686745 [TBL] [Abstract][Full Text] [Related]
39. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. Banatvala N; Griffin PM; Greene KD; Barrett TJ; Bibb WF; Green JH; Wells JG; J Infect Dis; 2001 Apr; 183(7):1063-70. PubMed ID: 11237831 [TBL] [Abstract][Full Text] [Related]
40. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli in white veal calves. Cristancho L; Johnson RP; McEwen SA; Gyles CL Vet Microbiol; 2008 Jan; 126(1-3):200-9. PubMed ID: 17656044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]